vimarsana.com
Home
Live Updates
Latus Bio secures $54m for CNS gene therapy development : comparemela.com
Latus Bio secures $54m for CNS gene therapy development
Latus Bio, a biotechnology company specialising in new gene therapy candidates for central nervous system (CNS) disorders, has announced its launch alongside an initial $54m Series A financing.
Related Keywords
Philadelphia ,
Pennsylvania ,
United States ,
Beverly Davidson ,
Latus Bio ,
Benjamin Franklin Technology Partners ,
Children Hospital Of Philadelphia Foundation ,
Samsung Life Science Fund ,
Philadelphia Foundation ,
Modi Ventures ,
Peter Ghoroghchian ,
comparemela.com © 2020. All Rights Reserved.